PhRMA Commits to ‘Responsible’ Patent Reforms

Drug Industry Daily
A A
PhRMA will back “responsible” drug patent reforms, but lawmakers would do well to remember how essential patent protections are to getting life-saving medicines to patients, one of the group’s executives told a Senate panel Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily